The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Thomas Modine

Showing 1-16 of 16 articles
Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report
Taramasso M, Sorajja P, Dahle G, Dumonteil N, Schäfer U, Modine T, Overtchouk P, Coisne A, Nickenig G, Babaliaros V, Khattab A, Ludwig S, Conradi L
June 25, 2021 | 10.4244/EIJ-D-19-00947
How to eliminate mitral regurgitation definitively: the eternal dilemma?
Modine T, Ben-Ali W
April 20, 2021 | 10.4244/EIJV16I17A252
Transaxillary compared with transcarotid access for TAVR: a propensity-matched comparison from a French multicentre registry
Debry N, Trimech T, Gandet T, Vincent F, Hysi I, Delhaye C, Cayla G, Koussa M, Juthier F, Leclercq F, Pécheux M, Ghostine S, Labreuche J, Modine T, Van Belle E
November 20, 2020 | 10.4244/EIJ-D-20-00117
Do we need alternative access in TAVR anymore?
Ben-Ali W, Overtchouk P, Modine T
February 7, 2020 | 10.4244/EIJV15I15A237
Will the PARTNER 3 Low Risk Trial change my practice?
McConkey H, Modine T, Latib A, Jüni P, Windecker S, Leon M
December 20, 2019 | 10.4244/EIJ-D-19-00847
Interventions for valvular disease
Transcatheter mitral valve replacement: factors associated with screening success and failure
Coisne A, Pontana F, Tchétché D, Richardson M, Longère B, Vahdat O, Berthoumieu P, Van Belle E, Rousse N, Lancellotti P, Montaigne D, Dumonteil N, Modine T
December 6, 2019 | 10.4244/EIJ-D-19-00444
Valvular heart disease: when does surgery remain the best option?
Overtchouk P, Vahanian A, Modine T
November 15, 2019 | 10.4244/EIJV15I10A157
Mitral valve regurgitation: a plea for transcatheter mitral valve replacement
Modine T, Prendergast B, Piazza N, Overtchouk P
September 20, 2019 | 10.4244/EIJV15I7A103
PCR London Valves Innovators Day 2017. Where will valve intervention be in 2025?
Dawkins S, Modine T, Windecker S, Piazza N, Prendergast B
November 20, 2017 | 10.4244/EIJV13I10A178
Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses: a multicentre propensity score analysis
Spaziano M, Mylotte D, Thériault-Lauzier P, De Backer O, Søndergaard L, Bosmans J, Debry N, Modine T, Barbanti M, Tamburino C, Sinning J, Grube E, Nickenig G, Mellert F, Bleiziffer S, Lange R, de Varennes B, Lachapelle K, Martucci G, Piazza N
November 20, 2017 | 10.4244/EIJ-D-16-00303
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Interventions for valvular disease
Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability
Thériault-Lauzier P, Mylotte D, Dorfmeister M, Spaziano M, Andalib A, Mamane S, Chetrit M, Blanke P, Cecere R, Buithieu J, Martucci G, Tchétché D, Modine T, Van Mieghem N, Lange R, Windecker S, Bilodeau L, Leipsic J, Piazza N
October 10, 2016 | 10.4244/EIJY15M11_09
Interventions for valvular disease
TAVI device selection: time for a patient-specific approach
Lee M, Modine T, Piazza N, Mylotte D
September 18, 2016 | 10.4244/EIJV12SYA9
Interventions for valvular disease
How should I treat a mitral prosthesis rupture after left ventricular assist device implantation?
Santise G, Nardella S, Leonetti S, Buioni D, Missiroli B, Di Marzio E, Maselli D, Mylotte D, Piazza N, Modine T, De Marco F, Garatti A, Testa L, Bedogni F
July 20, 2016 | 10.4244/EIJV12I4A89
Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system
Tchétché D, Modine T, Farah B, Vahdat O, Sudre A, Koussa M, Lereun C, Nejjari M, Choby M, Rosencher J, Sorbets E, Fajadet J
September 28, 2012 | 10.4244/EIJV8I5A86

Latest news

NEW ISSUE
EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…
July 20, 2021
Editorial
Treatment of secondary mitral regurgitation in patients with heart failure
Marco Metra et al
July 27, 2021
JAA
This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....
July 20, 2021
Editorial
Coronary flow capacity: where to next?
Nils P. Johnson
July 20, 2021
Ahead of print
Joint EAPCI/ACVC expert consensus document on pVADs
July 20, 2021
NEW
EuroIntervention's new impact factor!
July 1, 2021
STATE OF THE ART
Completeness of Revascularisation in ACS Patients with Multivessel Disease
Valeria Paradies et al.
June 25, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke